Alcresta Therapeutics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Alcresta Therapeutics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013152
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:20
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Alcresta Therapeutics Inc (Alcresta) develops and commercializes enzyme-based products for the treatment of gastrointestinal disorders and rare diseases. The company’s proprietary technology platform supports a pipeline of products that results in malabsorption common in cystic fibrosis, digestive cancers, and other serious diseases. It offers iLipase, to develop and market a range of novel, point of care, enzyme based products to support nutrition. Alcrestad’siLipase increases the absorption of fats crucial for growth and development, and improves the delivery, digestion and absorption of critical nutrients. The company also develops products indicated for exocrine pancreatic insufficiency caused by cystic fibrosis and other serious diseases. It caters to consumer and nutritional care markets. Alcresta is headquartered in Newton, Massachusetts, the US.

Alcresta Therapeutics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Alcresta Therapeutics Raises USD10 Million in Venture Financing 10
Alcresta Raises USD49.4 Million Financing 11
Alcresta Raises US$10 Million In Series B Financing 12
Alcresta Raises US$10 Million In Series A Financing 14
Partnerships 16
Alcresta Enters Into Co-Development Agreement With Cystic Fibrosis Foundation Therapeutics 16
Alcresta Therapeutics Inc – Key Competitors 17
Alcresta Therapeutics Inc – Key Employees 18
Alcresta Therapeutics Inc – Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20

List of Tables
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts 2
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Alcresta Therapeutics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Alcresta Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Alcresta Therapeutics Raises USD10 Million in Venture Financing 10
Alcresta Raises USD49.4 Million Financing 11
Alcresta Raises US$10 Million In Series B Financing 12
Alcresta Raises US$10 Million In Series A Financing 14
Alcresta Enters Into Co-Development Agreement With Cystic Fibrosis Foundation Therapeutics 16
Alcresta Therapeutics Inc, Key Competitors 17
Alcresta Therapeutics Inc, Key Employees 18

★海外企業調査レポート[Alcresta Therapeutics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Corum Group Ltd (COO):企業の財務・戦略的SWOT分析
    Summary Corum Group Ltd (Corum Group), is a technology company that owns businesses in technology and software development. The company offers point-of-sale and pharmaceutical dispensing software, support services and computer hardware. It provides products through corum health services and corum e- …
  • Duke Energy Corporation:企業の戦略・SWOT・財務情報
    Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report Summary Duke Energy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Foundation for Innovative New Diagnostics-製薬・医療分野:企業M&A・提携分析
    Summary Foundation for Innovative New Diagnostics (FIND) is a non-profit organization that offers diagnostic tests. The organization develops and implements new diagnostic technologies for the development of diagnostic tests. Its services include diagnostic technologies development, quality-assured …
  • Encore Wire Corporation:企業の戦略・SWOT・財務情報
    Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report Summary Encore Wire Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • HCA Healthcare Inc (HCA):製薬・医療:M&Aディール及び事業提携情報
    Summary HCA Healthcare Inc (HCA), formerly known as HCA Holdings Inc, is a health care services company that provides a wide range of services in specialties including internal medicine; general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics. It also offers outpatient and an …
  • Treet Corporation Ltd:企業の戦略・SWOT・財務情報
    Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report Summary Treet Corporation Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Vattenfall AB-エネルギー分野:企業M&A・提携分析
    Summary Vattenfall AB (Vattenfall) is a state-owned energy company that generates, distributes and sells electricity and heat. It is one of the leading generators of electricity and heat in Europe. The company also conducts the sale of gas and energy trading. Vattenfall generates power through vario …
  • Kobe Steel Ltd:企業の戦略・SWOT・財務情報
    Kobe Steel Ltd - Strategy, SWOT and Corporate Finance Report Summary Kobe Steel Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Sunovion Pharmaceuticals Inc:企業の戦略的SWOT分析
    Sunovion Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • PriceSmart, Inc. (PSMT):企業の財務・戦略的SWOT分析
    PriceSmart, Inc. (PSMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Boehringer Ingelheim GmbH:企業の戦略・SWOT・財務分析
    Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report Summary Boehringer Ingelheim GmbH - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sopheon Plc:企業の戦略・SWOT・財務情報
    Sopheon Plc - Strategy, SWOT and Corporate Finance Report Summary Sopheon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Saertex GmbH & Co KG:企業の戦略的SWOT分析
    Saertex GmbH & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野:企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • Culture Landmark Investment Ltd:企業の戦略・SWOT・財務分析
    Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report Summary Culture Landmark Investment Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BioMarin Pharmaceutical Inc (BMRN):企業の財務・戦略的SWOT分析
    BioMarin Pharmaceutical Inc (BMRN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Saudi Industrial Investment Group (2250):企業の財務・戦略的SWOT分析
    Summary Saudi Industrial Investment Group (SIIG) is a petrochemical company that invests, improves and develops petrochemical industry. The company produces cyclohexane, benzene, ethylene, polyethylene, hexane, polypropylene and polystyrene. It also provides propylene, styrene, motor gasoline blend, …
  • Nationwide Financial Services, Inc.:企業の戦略的SWOT分析
    Nationwide Financial Services, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Aker Solutions ASA (AKSO):石油・ガス:M&Aディール及び事業提携情報
    Summary Aker Solutions ASA (Aker Solutions) is a global provider of engineering, design, production systems and services to the oil and gas industry. The company offers subsea production equipment and offshore field design, ranging from concept studies and front-end engineering to subsea production …
  • BioFactura Inc-製薬・医療分野:企業M&A・提携分析
    Summary BioFactura Inc (Biofactura) is a biosimilars manufacturer that discovers, develops and markets biodefense drugs and client selected novel drugs. The company offers contract services such as process development, stable cell lines, and manufacturing. Its stable cell lines offers stable mammali …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆